National Research (NASDAQ:NRC - Get Free Report) is set to post its quarterly earnings results after the market closes on Tuesday, November 5th.
National Research (NASDAQ:NRC - Get Free Report) last issued its earnings results on Tuesday, August 6th. The company reported $0.26 earnings per share for the quarter. National Research had a return on equity of 64.43% and a net margin of 18.78%. The firm had revenue of $35.02 million for the quarter.
National Research Stock Performance
Shares of NRC traded down $1.00 during midday trading on Tuesday, hitting $17.77. 83,898 shares of the stock traded hands, compared to its average volume of 86,237. The business's 50 day moving average price is $20.84 and its two-hundred day moving average price is $24.86. The firm has a market capitalization of $424.19 million, a PE ratio of 14.33 and a beta of 0.49. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.37 and a current ratio of 0.37. National Research has a 1-year low of $17.73 and a 1-year high of $43.98.
National Research Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be given a dividend of $0.12 per share. The ex-dividend date is Friday, December 27th. This represents a $0.48 annualized dividend and a dividend yield of 2.70%. National Research's dividend payout ratio is presently 38.71%.
National Research Company Profile
(
Get Free Report)
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Read More
Before you consider National Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.
While National Research currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
